Detailed Narrative
FY26 Performance and Profitability
Despite global economic headwinds, Vidhi Specialty Food Ingredients Limited delivered a resilient performance in FY26. Revenue stood at INR 380 crores, a slight decrease from INR 382.30 crores in FY25. However, EBITDA improved to INR 78 crores from INR 68 crores, with margins expanding to 20.52% from 17.91%. Net profit grew by 10.80% to INR 49.15 crores, demonstrating strong profitability management even in a challenging environment.
Strategic Transformation and Product Development
The company is accelerating its strategic transformation, focusing on higher value-added and application-driven segments. Significant progress has been made on the CoatIcon range of tablet coating systems, which are in aggressive sampling and customer qualification stages with several multi-pharmaceutical companies. The R&D pipeline remains robust, with multiple new product ranges under development, aligning with the vision of a diversified specialty ingredients platform catering to food, pharmaceutical, cosmetics, and allied industries.
Capex Plans and Timelines for New Projects
Vidhi plans to invest INR 5-12 crores for the CoatIcon pharma product line scale-up and INR 75-85 crores in the first phase for other new products. Most of this capex is expected to be spent in FY27. Commissioning for these new product lines is anticipated in the middle of financial year '27-'28. Additionally, the company has invested INR 4.5-5 crores in analytical equipment for its R&D facilities, which house over 60 dedicated chemists.
Margin Expansion and Product Mix Optimization
The EBITDA margin on manufactured sales was close to 24-25% in FY26, and overall EBITDA margins are expected to rise further as value-added and specialized products increase in quantity. The contribution of high-margin, high-value products in the total portfolio is currently around 5% and is expected to double to 10-12% (or higher) in FY27. This shift is a key strategy for sustainable growth and improved profitability, with new product lines expected to have excellent margin profiles due to thin competition.
US Market Dynamics and Export Performance
The US market, a significant export destination, experienced volatility due to tariff issues, but the company managed to sustain sales. Management clarified that the export share to the US is 19% (for North America, not 44%) and that there is no US plan to ban synthetic food colors. While other markets like the Middle East, Bangladesh, and Philippines are currently facing economic slowdowns, the company expects the US market to open up substantially as geopolitical situations stabilize, leading to sharper demand.
Financial Health and Ratios
The company maintains a robust financial position with a low debt-to-equity ratio of 0.28%. Return on capital employed improved to 20.90% from 20.17%, and return on equity increased to 14.94% from 14.92%. The interest coverage ratio, however, reduced from 28.27% to 16.75% due to the withdrawal of the export finance subvention scheme by the Indian government in December 2025, which increased finance costs.
Capacity Utilization and Future Outlook
Vidhi expects full utilization of both its Dahej and Roha facilities in FY27, indicating robust demand and operational efficiency. The company's long-term vision includes a product pipeline for the next decade, with new products being commercialized every 18-24 months. The Dahej project, once commissioned, is expected to generate INR 125-150 crores in sales, contributing significantly to future revenue growth.